Re: Kucharz EJ, Kovalenko V, Szántó S, et al. A review of glucosamine for knee osteoarthritis: why patented crystalline glucosamine sulfate should be differentiated from other glucosamines to maximize clinical outcomes. Curr Med Res Opin 2016;32:997-1004
Re. E.J. KUCHARZ, et al. A review of glucosamine for knee osteoarthritis. why patented crystalline glucosamine sulfate should be differentiated from the other glucosamines to .... Cur Med Res.pdf
Reginster, Jean-Yves ; Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé
Cooper, C.; MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton, United Kingdom
Bruyère, Olivier ; Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé
Title :
Re: Kucharz EJ, Kovalenko V, Szántó S, et al. A review of glucosamine for knee osteoarthritis: why patented crystalline glucosamine sulfate should be differentiated from other glucosamines to maximize clinical outcomes. Curr Med Res Opin 2016;32:997-1004
E.J.Kucharz, V.Kovalenko, S.Szanto,. A review of glucosamine for knee osteoarthritis:why patented crystalline glucosamine sulfate should be differentiated from other glucosamines to maximize clinical outcomes. Curr Med Res Opin 2016;32:997-1004
R.Chiusaroli, T.Piepoli, T.Zanelli,. Experimental pharmacology of glucosamine sulfate. Int J Rheumatol 2011;2011:939265
S.Taniguchi, J.Ryu, M.Seki,. Long-term oral administration of glucosamine or chondroitin sulfate reduces destruction of cartilage and up-regulation of MMP-3 mRNA in a model of spontaneous osteoarthritis in Hartley guinea pigs. J Orthop Res 2012;30:673-8
E.J.Uitterlinden, H.Jahr, J.L.Koevoet,. Glucosamine decreases expression of anabolic and catabolic genes in human osteoarthritic cartilage explants. Osteoarthritis Cartilage 2006;14:250-7
I.Setnikar, C.Giacchetti, G.Zanolo Pharmacokinetics of glucosamine in the dog and in man. Arzneimittelforschung 1986;36:729-35
S.Persiani, E.Roda, L.C.Rovati,. Glucosamine oral bioavailability and plasma pharmacokinetics after increasing doses of crystalline glucosamine sulfate in man. Osteoarthritis Cartilage 2005;13:1041–9
P.Eriksen, E.M.Bartels, R.D.Altman,. Risk of bias and brand explain the observed inconsistency in trials on glucosamine for symptomatic relief of osteoarthritis:a meta-analysis of placebo-controlled trials. Arthritis Care Res (Hoboken) 2014;66:1844–55
